Antibody Cocktail May Curb Infection in Unvaccinated Exposed to COVID-19
MONDAY, April 12, 2021 -- People living with someone who has COVID-19 appear to get powerful protection against infection when they are given the Regeneron antibody cocktail, a new study shows.
The findings suggest that beyond preventing the worst outcomes for coronavirus infection when given early enough, the cocktail could also prevent people from getting sick in the first place, the company said Monday, according to The New York Times.
In its statement, Regeneron said it would ask the U.S. Food and Drug Administration to expand the drug's emergency authorization use -- for high-risk people who already have COVID-19 but are not hospitalized -- to allow it to be given for preventive purposes in "appropriate populations."
The new data on the Regeneron antibody cocktail come from a clinical trial that enrolled more than 1,500 people who lived in the same house as someone who had tested positive for the virus within the previous four days. Those who received an injection of the Regeneron drug were 81 percent less likely to get sick with COVID-19 compared with volunteers who received placebo, the company said.
The Regeneron antibody cocktail, a combination of two drugs designed to mimic the antibodies generated naturally when the immune system fends off the virus, received emergency authorization last November. Doctors are using it, as well as another antibody cocktail from Eli Lilly, for high-risk COVID-19 patients to guard against severe disease and hospitalization. But many hospitals and clinics have not made the treatments a priority because they are time-consuming and difficult to administer, mostly because they must be given intravenously. Regeneron plans to ask the FDA to allow its drug to be given via an injection, as it was in the latest study, which would allow it to be given more quickly and easily.
© 2021 HealthDay. All rights reserved.
Posted: April 2021
Further Support and Information on COVID-19
Read this next
WEDNESDAY, May 12, 2021 -- The American Medical Association released a plan on Tuesday to confront structural racism inside the organization and the entire U.S. medical...
WEDNESDAY, May 12, 2021 -- Idiopathic intracranial hypertension (IIH) is more likely among Black and Hispanic women, as well as those living in low-income tracts and food swamps,...
WEDNESDAY, May 12, 2021 -- About 11 percent of U.K. adults experienced deteriorating or consistently poor mental health during the COVID-19 pandemic, according to a study...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.